We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$759M
AUM Growth
+$54M
Cap. Flow
+$13.7M
Cap. Flow %
1.8%
Top 10 Hldgs %
47.42%
Holding
89
New
4
Increased
57
Reduced
16
Closed

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.23M
2
KRYS icon
Krystal Biotech
KRYS
+$3.12M
3
FICO icon
Fair Isaac
FICO
+$563K
4
COHR icon
Coherent
COHR
+$547K
5
UNH icon
UnitedHealth
UNH
+$371K

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$714K
2
NVDA icon
NVIDIA
NVDA
+$628K
3
AMZN icon
Amazon
AMZN
+$518K
4
IDXX icon
Idexx Laboratories
IDXX
+$403K
5
MA icon
Mastercard
MA
+$358K

Sector Composition

Rank Sector Weight
1 Technology 29.73%
2 Healthcare 26.51%
3 Financials 8.64%
4 Consumer Discretionary 7.75%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
26
Lockheed Martin
LMT
$133B
$10.7M 1.42%
23,203
+536
+2% +$251K
ASML icon
27
ASML
ASML
$645B
$10.5M 1.38%
13,068
+37
+0.3% +$26.6K
ITW icon
28
Illinois Tool Works
ITW
$85.5B
$10.4M 1.38%
42,214
+1,329
+3% +$321K
CVX icon
29
Chevron
CVX
$366B
$10.4M 1.37%
72,591
+2,169
+3% +$306K
XYZ
30
Block Inc
XYZ
$50.1B
$10.3M 1.36%
152,029
+2,975
+2% +$173K
AMGN icon
31
Amgen
AMGN
$221B
$10M 1.32%
35,814
+1,015
+3% +$288K
JNJ icon
32
Johnson & Johnson
JNJ
$621B
$9.67M 1.28%
63,329
+1,967
+3% +$302K
VZ icon
33
Verizon
VZ
$193B
$8.44M 1.11%
195,001
+6,585
+3% +$285K
TMDX icon
34
Transmedics
TMDX
$2.65B
$7.84M 1.03%
58,480
+410
+0.7% +$45K
GIS icon
35
General Mills
GIS
$19.2B
$7.31M 0.96%
141,009
+5,401
+4% +$298K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$7.18M 0.95%
155,152
+6,259
+4% +$307K
PRCT icon
37
Procept Biorobotics
PRCT
$1.1B
$6.88M 0.91%
119,449
+2,535
+2% +$143K
TEAM icon
38
Atlassian
TEAM
$28.8B
$6.82M 0.9%
33,562
-10
-0% -$2.08K
NVO
39
Novo Nordisk
NVO
$197B
$6.32M 0.83%
+91,550
New +$6.23M
UNH icon
40
UnitedHealth
UNH
$375B
$6.31M 0.83%
20,213
+971
+5% +$371K
SBUX icon
41
Starbucks
SBUX
$121B
$5.69M 0.75%
62,130
+985
+2% +$85.4K
REGN icon
42
Regeneron Pharmaceuticals
REGN
$79.1B
$4.46M 0.59%
8,501
+40
+0.5% +$22.3K
FANG icon
43
Diamondback Energy
FANG
$52.1B
$3.99M 0.53%
29,075
+217
+0.8% +$30.1K
SHOP icon
44
Shopify
SHOP
$187B
$3.39M 0.45%
29,369
+290
+1% +$29K
MTUM icon
45
iShares MSCI USA Momentum Factor ETF
MTUM
$26.3B
$2.97M 0.39%
12,365
+97
+0.8% +$21.2K
IWF icon
46
iShares Russell 1000 Growth ETF
IWF
$127B
$2.95M 0.39%
27,764
+248
+0.9% +$23.7K
KRYS icon
47
Krystal Biotech
KRYS
$9.64B
$2.92M 0.38%
+21,240
New +$3.12M
IWP icon
48
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
$2.83M 0.37%
20,392
+366
+2% +$46.3K
ZTS icon
49
Zoetis
ZTS
$31.2B
$2.82M 0.37%
18,067
+55
+0.3% +$8.72K
DWAS icon
50
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$2.16M 0.29%
25,480
+1,172
+5% +$92.8K

Similar funds

Biondo Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Biondo Investment Advisors held 89 positions worth $759M, up 7.7% from $705M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 4.5%. Biondo Investment Advisors opened 4 new positions and made no exits, leaving the 89-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Biondo Investment Advisors's largest Q2 2025 buy was Novo Nordisk: 91,550 shares worth $6.32M.
  • Biondo Investment Advisors added most to Fair Isaac in Q2 2025, an estimated $563K increase.
  • Biondo Investment Advisors's biggest Q2 2025 reduction was Intuitive Surgical, cutting an estimated $714K.
  • Biondo Investment Advisors's ten largest holdings make up 47% of its $759M portfolio in Q2 2025.
  • Biondo Investment Advisors opened 4 new positions and closed 0 in Q2 2025.
  • Biondo Investment Advisors's portfolio value rose 7.7% quarter-over-quarter to $759M.

Based on Biondo Investment Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.